Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 24.70
+0.50 (2.07%)
Aug 24, 2026, 10:48 AM IDT
TLV:CBI Revenue
Clal Biotechnology Industries had revenue of -118.00K ILS in the twelve months ending June 30, 2026.
Revenue (ttm)
-118.00K
Revenue Growth
n/a
P/S Ratio
-321.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
37.96M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 104.00K | -266.00K | -71.89% |
| Dec 31, 2022 | 370.00K | 146.00K | 65.18% |
| Dec 31, 2021 | 224.00K | 18.00K | 8.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Evogene | 5.82M |
| BioLineRx | 4.43M |
| Can-Fite BioPharma | 1.29M |
| Geffen Residence & Renewal | 79.00K |
| BioLight Life Sciences | 21.00K |